Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI

Biol Chem. 2003 Jul;384(7):1103-7. doi: 10.1515/BC.2003.123.

Abstract

Mouse polyclonal antibodies against placental cysteine proteinase inhibitor (CPI) react with the placental 67 kDa CPI on Western blots, and CPI present in ovarian cancer homogenate and serum was shown by double immunodiffusion to react with the same antiserum. By immunohistochemical staining, positive expression of high molecular weight CPI was observed on the tumour cell surface in serous and endometrioid ovarian carcinomas with metastasis. Normal endometrioid tissue was not stained with anti-placental CPI antibodies. Cathepsin B and pro-cathepsin B median levels in ovarian cancer tissue homogenates increased progressively with FIGO stage of the disease. The enzyme level decreased 22-fold after treatment of tissue homogenates with 5 nM purified CPI. These results provide evidence that addition of CPI reduces the levels of cysteine-type cathepsins to those of normal non-cancerous values.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antibodies / immunology*
  • Cathepsin B / biosynthesis
  • Cathepsin B / metabolism*
  • Cysteine Proteinase Inhibitors / biosynthesis
  • Cysteine Proteinase Inhibitors / genetics
  • Cysteine Proteinase Inhibitors / immunology
  • Cysteine Proteinase Inhibitors / metabolism*
  • Enzyme Precursors / metabolism
  • Female
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Molecular Weight
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • Placenta / enzymology
  • Placenta / immunology
  • Placenta / metabolism*
  • Tissue Extracts / metabolism

Substances

  • Antibodies
  • Cysteine Proteinase Inhibitors
  • Enzyme Precursors
  • Tissue Extracts
  • procathepsin B
  • Cathepsin B